ConductScience.org, home

Paper41428107

A signature constructed with circadian rhythm-related genes to predict the prognosis and therapy response for low-grade gliomas.

Zhou Y and 3 others. Discov Oncol, 2025. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. A signature constructed with circadian rhythm-related genes to predict the prognosis and therapy response for low-grade gliomas. Papers, record 41428107. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41428107

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A signature constructed with circadian rhythm-related genes to predict the prognosis and therapy response for low-grade gliomas.
PubMed
Journal
Discov Oncol
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-01-01
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhou YYiqiang
2Ke RRuwei
3Hu ZZiliang
4Wang ZZhepei

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References44

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135468964HOXB13 suppresses de novo lipogenesis through HDAC3-mediated epigenetic reprogramming in prostate cancer.Nat Genet2022https://conductscience.org/library/papers/35468964PubMed
229643471Current state of immunotherapy for glioblastoma.Nat Rev Clin Oncol2018https://conductscience.org/library/papers/29643471PubMed
331126321Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data.Genome Med2019https://conductscience.org/library/papers/31126321PubMed
426516226Immunosuppressive mechanisms in glioblastoma.Neuro Oncol2015https://conductscience.org/library/papers/26516226PubMed
535877357Effects and Prognostic Values of Circadian Genes CSNK1E/GNA11/KLF9/THRAP3 in Kidney Renal Clear Cell Carcinoma via a Comprehensive Analysis.Bioengineering (Basel)2022https://conductscience.org/library/papers/35877357PubMed
639248287EGFR and EGFRvIII coopt host defense pathways promoting progression in glioblastoma.Neuro Oncol2025https://conductscience.org/library/papers/39248287PubMed
736920044Circular RNA ACACA negatively regulated p53-modulated mevalonate pathway to promote colorectal tumorigenesis via regulating miR-193a/b-3p/HDAC3 axis.Mol Carcinog2023https://conductscience.org/library/papers/36920044PubMed
816199517Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.Proc Natl Acad Sci U S A2005https://conductscience.org/library/papers/16199517PubMed
933264103TRIM27 acts as an oncogene and regulates cell proliferation and metastasis in non-small cell lung cancer through SIX3-β-catenin signaling.Aging (Albany NY)2020https://conductscience.org/library/papers/33264103PubMed
1039098678Biohybrid hydrogel inhibiting β-klotho/HDAC3 axis for hepatocellular carcinoma treatment.Int J Biol Macromol2024https://conductscience.org/library/papers/39098678PubMed
1124083766Lgr4 promotes glioma cell proliferation through activation of Wnt signaling.Asian Pac J Cancer Prev2013https://conductscience.org/library/papers/24083766PubMed
1210592173KEGG: kyoto encyclopedia of genes and genomes.Nucleic Acids Res2000https://conductscience.org/library/papers/10592173PubMed
1332442275TIMER2.0 for analysis of tumor-infiltrating immune cells.Nucleic Acids Res2020https://conductscience.org/library/papers/32442275PubMed
1425485508Loss of circadian clock gene expression is associated with tumor progression in breast cancer.Cell Cycle2014https://conductscience.org/library/papers/25485508PubMed
1536683050Mesothelioma-associated fibroblasts enhance proliferation and migration of pleural mesothelioma cells via c-Met/PI3K and WNT signaling but do not protect against cisplatin.J Exp Clin Cancer Res2023https://conductscience.org/library/papers/36683050PubMed
1632398667Insulin-like growth factor 1-induced enolase 2 deacetylation by HDAC3 promotes metastasis of pancreatic cancer.Signal Transduct Target Ther2020https://conductscience.org/library/papers/32398667PubMed
1724789043Induction of the CLOCK gene by E2-ERα signaling promotes the proliferation of breast cancer cells.PLoS One2014https://conductscience.org/library/papers/24789043PubMed
1818976072Recurrence following neurosurgeon-determined gross-total resection of adult supratentorial low-grade glioma: results of a prospective clinical trial.J Neurosurg2008https://conductscience.org/library/papers/18976072PubMed
1915737082Survival model predictive accuracy and ROC curves.Biometrics2005https://conductscience.org/library/papers/15737082PubMed
2023254314Circadian gene expression and clinicopathologic correlates in pancreatic cancer.J Gastrointest Surg2013https://conductscience.org/library/papers/23254314PubMed

See all 44 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41428107

GET https://conductscience.org/api/papers/v1/41428107/references?page=2